$111 Million is the total value of Endurant Capital Management LP's 43 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TMO | New | THERMO FISHER SCIENTIFIC INC | $7,009,948 | – | 13,849 | +100.0% | 6.30% | – |
| AVTR | New | AVANTOR INC | $4,782,567 | – | 226,877 | +100.0% | 4.30% | – |
| CNMD | New | CONMED CORP | $4,234,086 | – | 41,984 | +100.0% | 3.80% | – |
| COO | New | COOPER COS INC | $3,667,609 | – | 11,533 | +100.0% | 3.29% | – |
| HUM | New | HUMANA INC | $3,203,248 | – | 6,584 | +100.0% | 2.88% | – |
| TXG | New | 10X GENOMICS INC | $2,930,565 | – | 71,044 | +100.0% | 2.63% | – |
| SBRA | New | SABRA HEALTH CARE REIT INC | $2,840,860 | – | 203,792 | +100.0% | 2.55% | – |
| OHI | New | OMEGA HEALTHCARE INVS INC | $2,655,121 | – | 80,070 | +100.0% | 2.38% | – |
| ABC | New | CENCORA INC | $2,088,732 | – | 11,606 | +100.0% | 1.88% | – |
| SYK | New | STRYKER CORPORATION | $2,062,369 | – | 7,547 | +100.0% | 1.85% | – |
| ZBH | New | ZIMMER BIOMET HOLDINGS INC | $1,961,493 | – | 17,479 | +100.0% | 1.76% | – |
| New | QUIDELORTHO CORP | $1,953,601 | – | 26,747 | +100.0% | 1.76% | – | |
| DXCM | New | DEXCOM INC | $1,930,750 | – | 20,694 | +100.0% | 1.73% | – |
| ABT | New | ABBOTT LABS | $1,747,174 | – | 18,040 | +100.0% | 1.57% | – |
| PODD | New | INSULET CORP | $1,415,952 | – | 8,878 | +100.0% | 1.27% | – |
| HOLX | New | HOLOGIC INC | $1,231,850 | – | 17,750 | +100.0% | 1.11% | – |
| BRKS | New | AZENTA INC | $974,790 | – | 19,422 | +100.0% | 0.88% | – |
| TARS | New | TARSUS PHARMACEUTICALS INC | $846,723 | – | 47,649 | +100.0% | 0.76% | – |
| AHCO | New | ADAPTHEALTH CORP | $818,427 | – | 89,937 | +100.0% | 0.74% | – |
| AXSM | New | AXSOME THERAPEUTICS INC | $786,542 | – | 11,254 | +100.0% | 0.71% | – |
| New | VENTYX BIOSCIENCES INC | $641,046 | – | 18,458 | +100.0% | 0.58% | – | |
| New | ARCELLX INC | $507,989 | – | 14,158 | +100.0% | 0.46% | – | |
| GDRX | New | GOODRX HLDGS INC | $491,443 | – | 87,290 | +100.0% | 0.44% | – |
| TLT | New | ISHARES TR20 yr tr bd etf | $301,546 | – | 3,400 | +100.0% | 0.27% | – |
| NVST | New | ENVISTA HOLDINGS CORPORATION | $300,742 | – | 10,787 | +100.0% | 0.27% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LABORATORY CORP AMER HLDGS | 31 | Q2 2023 | 8.7% |
| ELEVANCE HEALTH INC | 29 | Q3 2023 | 8.8% |
| BECTON DICKINSON & CO | 28 | Q2 2023 | 9.8% |
| MCKESSON CORP | 27 | Q1 2023 | 4.4% |
| CENCORA INC | 26 | Q3 2023 | 5.9% |
| HOLOGIC INC | 24 | Q3 2023 | 7.5% |
| JOHNSON & JOHNSON | 24 | Q4 2021 | 5.5% |
| ZIMMER HLDGS INC | 23 | Q3 2023 | 7.5% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2023 | 5.5% |
| DAVITA INC | 22 | Q1 2021 | 4.9% |
View Endurant Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AZIYO BIOLOGICS, INC. | March 21, 2023 | 576,253 | 4.9% |
| Oxford Immunotec Global PLCSold out | February 17, 2021 | 0 | 0.0% |
View Endurant Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-10 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13D/A | 2023-09-08 |
| 13F-HR | 2023-08-14 |
| 3/A | 2023-05-24 |
| 13F-HR | 2023-05-15 |
| 3 | 2023-05-15 |
| SC 13D | 2023-05-15 |
| SC 13G/A | 2023-03-21 |
View Endurant Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.